Quick Answer
Pediatrix Medical Group, Inc. reported Diluted EPS of $1.94 per share for fiscal year 2025.
Pediatrix Medical Group, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $1.94 | +263.0% |
| 2024 | -$1.19 | -63.0% |
| 2023 | -$0.73 | -192.4% |
| 2022 | $0.79 | -48.4% |
| 2021 | $1.53 | +116.0% |
| 2020 | -$9.55 | +46.4% |
| 2019 | -$17.83 | -708.5% |
| 2018 | $2.93 | -15.1% |
| 2017 | $3.45 | -1.1% |
| 2016 | $3.49 | -2.5% |
| 2015 | $3.58 | +12.6% |
| 2014 | $3.18 | +14.4% |
| 2013 | $2.78 | +14.9% |
| 2012 | $2.42 | +8.5% |
| 2011 | $2.23 | -47.7% |
| 2010 | $4.26 | +12.7% |
| 2009 | $3.78 | +5.3% |
| 2008 | $3.59 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.84 | +265.2% | +82.6% |
| June 30, 2025 | $0.46 | +125.0% | +91.7% |
| March 31, 2025 | $0.24 | +380.0% | +4.3% |
| September 30, 2024 | $0.23 | -11.5% | +112.5% |
| June 30, 2024 | -$1.84 | -641.2% | -3780.0% |
| March 31, 2024 | $0.05 | -70.6% | -80.8% |
| September 30, 2023 | $0.26 | -29.7% | -23.5% |
| June 30, 2023 | $0.34 | +6.3% | +100.0% |
- Pediatrix Medical Group, Inc. showed an increase of +263.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2008–2025 period, Pediatrix Medical Group, Inc.’s diluted eps has declined by 46.0% (from $3.59 per share to $1.94 per share).
- The most recent figure is from Pediatrix Medical Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: